Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01070979 · ClinicalTrials.gov registry record · Phase 3
Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms.
A Phase 3 study, sponsored by Warner Chilcott.
- Completed
- Registry status
- Phase 3
- Development phase
- 249
- Enrollment target
NCT01070979 is a Phase 3 study that has completed, run by Warner Chilcott. The registered enrollment target is 249 participants.
The verdict
NCT01070979, a Phase 3 study, has completed, sponsored by Warner Chilcott.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 249 participants
- Enrollment target
Study Summary
Multicenter, double-blind, controlled, parallel group, randomized study to compare the clinical benefit of Estradiol acetate tablets, estradiol tablets and conjugated equine estrogen tablets, each administered orally, once daily, to postmenopausal women.
Interventions
- DRUG Estradiol
- DRUG Estradiol acetate
- DRUG Conjugated equine estrogens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 249 participants |
| Start Date | 2003-02 |
| Est. Completion | 2003-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01070979
The ClinicalTrials.gov registry entry for NCT01070979 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 249 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Warner Chilcott, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Estradiol is the first listed.
NCT01070979 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01070979 about?
NCT01070979 is a clinical study titled "Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms.". Multicenter, double-blind, controlled, parallel group, randomized study to compare the clinical benefit of Estradiol acetate tablets, estradiol tablets and conjugated equine estrogen tablets, each administered orally, once daily, to postmenopausal women.
What is the current status of trial NCT01070979?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 249 participants. The study started on 2003-02. Estimated completion is 2003-09.
What interventions are being tested in trial NCT01070979?
The interventions under investigation include: Estradiol (DRUG), Estradiol acetate (DRUG), Conjugated equine estrogens (DRUG).
Who is sponsoring clinical trial NCT01070979?
This trial is sponsored by Warner Chilcott, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.